Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome

Takeshi Mizukami; Shinya Sugimoto; Tatsuhiro Masaoka; Hidekazu Suzuki; Takanori Kanai

doi:10.5217/ir.2017.15.2.236

Articles

Page Path: HOME > Intest Res > Volume 15(2); 2017 > Article

Original Article Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome: Takeshi Mizukami¹, Shinya Sugimoto², Tatsuhiro Masaoka², Hidekazu Suzuki³, Takanori Kanai²; Intestinal Research 2017;15(2):236-243.
DOI: https://doi.org/10.5217/ir.2017.15.2.236
Published online: April 27, 2017

¹Endoscopy Center, NHO Kurihama Medical and Addiction Center, Yokosuka, Japan.

²Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.

³Medical Education Center, Keio University School of Medicine, Tokyo, Japan.

Correspondence to: Takeshi Mizukami, Endoscopy Center, NHO Kurihama Medical and Addiction Center, 5-3-1 Nobi, Yokosuka, Kanagawa 239-0841, Japan. Tel: +81-4-68481550, Fax: +81-4-68497743, mi-zukami@violin.ocn.ne.jp

*These authors contributed equally to this study.

• Received: October 10, 2016 • Revised: December 4, 2016 • Accepted: December 6, 2016

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

35,151 Views
92 Download
6 Web of Science
8 Crossref
12 Scopus

Full Article

Download PDF

Abstract
INTRODUCTION
METHODS
RESULTS
DISCUSSION
Acknowledgments
ACKNOWLEDGEMENTS
NOTES
REFERENCES

Abstract

Background/Aims
Colonoscopy and computed tomography (CT) are used primarily to exclude organic diseases in patients with irritable bowel syndrome (IBS), rather than to assess the pathophysiology of IBS. We aimed to evaluate colonic dysmotility and morphology in Japanese patients with IBS.
Methods
One hundred eighty-four patients with IBS and 49 asymptomatic controls who underwent colonoscopy in combination with CT colonography or barium enema were retrospectively reviewed between 2008 and 2012. Water-aided colonoscopy was performed without sedation by a single endoscopist. The duration and pattern of colonic movement and cecal intubation time were recorded. To assess colonic morphology, barium enema or CT colonography were performed immediately after colonoscopy.
Results
Colonic dysmotility was more frequent in the IBS group (28.8% vs. 2.0% in controls, P<0.001), especially in cases of IBS with diarrhea (IBS-D) (IBS with constipation [IBS-C] 28.8% vs. IBS-D 60.0% vs. mixed IBS [IBS-M] 5.1%, P<0.001). Colonic morphological abnormality was more frequent in the IBS group than in the control group (77.7% vs. 24.5%, P<0.001), especially in IBS-M and IBS-C groups (IBS-C 77.5% vs. IBS-D 48.9% vs. IBS-M 100%, P<0.001). Most patients with IBS with colonic dysmotility had experienced stress related to their symptoms. Cecal intubation time was significantly longer in the IBS group than in the control group (12.1±6.9 minutes vs. 4.6±1.9 minutes, P<0.001).
Conclusions
Unsedated colonoscopy, combined with radiographic findings, can detect colonic dysmotility and morphological abnormality. Technical difficulties observed during cecal intubation may partially explain the pathophysiology of IBS.
Keywords: Colonoscopy; Irritable bowel syndrome; Water immersion; Sedation; Radiography

INTRODUCTION

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that affects patients' quality of life.1 IBS is characterized by symptoms such as abdominal pain or discomfort, alteration of bowel habits, relief of symptoms upon defecation, aggravation because of psychological strain, symptom-free periods during sleep, and absence of organic abnormalities on colorectal examination.2 Prevalence ranges from 10% to 15% of the general population in major developed countries.3

It is well recognized that stress,4 psychological disorders,5 visceral hypersensitivity, and colonic spasms6 are related to the pathophysiology of IBS. In the Rome III criteria,2 IBS is diagnosed mainly by clinical symptoms since pathognomonic diagnostic measurements for IBS are still lacking. Four IBS subtypes, IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), mixed IBS (IBS-M), and unsubtyped IBS, are classified based on the predominant stool pattern only.2 In the differential diagnosis of IBS, colonoscopy and CT are used primarily to exclude organic diseases, rather than to evaluate colonic motility and morphology. Therefore, limited information is obtained from these examinations on patients with IBS.

Several pathophysiological mechanisms have been suggested to underlie IBS, including effects of microbiota,7 mucosal inflammation,8 immune system alterations,9 and altered intestinal motility.10 Although diagnostic criteria for IBS have been developed, including the Manning and Rome I, II, and III criteria, there is no information on the involvement of mental stress.

Since psychosocial stress can be exacerbated because of endoscopic procedures, we focused on the persistent colonic dysmotility observed in response to the psychological stress of the colonoscopy procedure itself in the present study.11 However, while sedation can reduce discomfort, it can also mask the psychological influence of the colonoscopy procedure on colonic motility. We have previously reported the water-aided colonoscope insertion technique, called the “collapse-submergence method” or “water-navigation method.”12 13 14 15 Using this technique, colonoscopy can be performed without the administration of sedatives. When colonoscopy was performed without sedatives during cancer screening in men, colonic movements such as peristalsis and spasm persisted for ≥8 minutes after administration of scopolamine butyl bromide in approximately 14% of the population.11 Most of the patients included in the screening had historical symptoms of IBS or symptoms at the time of the examination. Accordingly, we formed a hypothesis that persistent colonic dysmotility associated with IBS can be observed during endoscopy in response to the psychological stress of the colonoscopy procedure, while dysmotility in healthy individuals is suppressed by antispasmodics.

Insertion of the colonoscope into the cecum is often difficult in patients with defecatory disorder, because of colonic morphological abnormalities, such as elongation and acute angulation.16 However, the role of colonic morphology in the pathophysiology and management of IBS is unknown. We also formed the hypothesis that some patients with IBS do not have persistent colonic dysmotility, and most of them have colonic morphological abnormalities, such as mesocolon descendens and sigmoid colon malrotation. CT colonography (CTC) is useful for excluding organic diseases and for producing a three-dimensional image of the colon.17 CTC or barium enema can reveal colonic morphology.

In the present study, we aimed to evaluate colonic dysmotility and morphology in patients with each subtype of IBS using colonoscopy in combination with CTC or barium enema, and to assess the pathophysiology of IBS.

METHODS

1. Ethical Considerations

The study protocols were reviewed and approved by the Ethics Committee of Kurihama Medical and Addiction Center (number: 151) and the Yokohama Municipal Citizen's Hospital (number: 20070910-1), Kanagawa, Japan. All study participants, or their legal guardians, provided written informed consent for unsedated colonoscopy and CTC or barium enema.

2. Participants

Between January 2008 and January 2012, we recruited 49 asymptomatic individuals without defecatory disorder who underwent colonoscopy for colorectal cancer screening, and 184 patients with IBS. We excluded patients with diabetes, liver diseases, gastrointestinal surgical history, or malignancy. After informed consent was obtained, colonoscopy in combination with CTC or barium enema was performed to evaluate colonic dysmotility and morphology. Participants were interviewed to determine their symptoms, and the diagnosis of IBS was based on the Rome III criteria.2 Although the colonoscopic evaluation was carried out at the time of performance of the colonoscopy, and patients' symptoms were recorded at the time of examination, this study was retrospectively conducted.

3. Colonoscopy

All participants underwent bowel preparation before colonoscopy. To prevent bowel spasm, scopolamine butyl bromide (20 mg) or glucagon (1 mg) was injected intramuscularly, and no sedatives were administered. All colonoscopies were performed by a single trained endoscopist (T. Mizukami), and cecal intubation time was recorded. This endoscopist was a well-trained board certified specialist of the Japan Gastroenterological Endoscopy Society with over 18 years and 18,000 cases of colonoscopy experience. All procedures were performed using water-aided colonoscopy, called the “collapse-submergence method” or “water-navigation colonoscopy.” This entailed infusion of water in lieu of air insufflation to distend the lumen during the insertion phase of colonoscopy, as previously described.12 13

4. Definition and Evaluation of Colonic Dysmotility

We recorded the duration of persistence of colonic movement after administration of an antispasmodic agent and the pattern of colonic movement in the entire colon. The endpoint of colonic movement was defined as absence of peristalsis/segmental movement over a period of 30 seconds (Fig. 1A). Persistence of colonic dysmotility for >8 minutes after administration of an antispasmodic agent was defined as colonic dysmotility.11 Patterns of dysmotility were evaluated and classified as spontaneous colonic excessive peristalsis and segmental contractions. Colonoscopic view showed spontaneous, excessive colonic peristalsis that prevented further advancement of the endoscope. Excessive colonic contraction forces stool through the colon, resulting in diarrhea (Fig. 1B). Segmental movement was defined as the combined presence of physiological retraction rings and expanded colonic lumen, and physiological retraction rings contracted and relaxed at the same point. Colonoscopic view showed colonic dysmotility with segmental features that prevented further advancement of the endoscope. The colon maintained segmental contractions, thus affecting stool transit, resulting in constipation (Fig. 1C).

5. Definition and Evaluation of Morphological Abnormality

As a result of changes in the water surface and the direction of colonic rotation, colonic morphology was approximately determined using water-aided colonoscopy.15 We confirmed colonic morphology using barium enema or CTC, immediately after colonoscopic observation, with complete suction of debris and fluid in the colonic lumen. Colonic morphology around the hindgut area, such as sigmoid malrotation (Fig. 2A) and mesocolon descendens (Fig. 2B and C), was evaluated. Morphological abnormality was assessed by a single trained physician (T. Mizukami), who had the experience of performing 30 autopsies to evaluate colonic morphology in the Department of Anatomy, Keio University School of Medicine, Tokyo, Japan. The evaluation was approved by another physician (S.S.).

6. Questionnaire Regarding Related Stress

Participants with IBS were asked whether their IBS symptoms began after an episode of stress, or if they were triggered by daily mental stress.

7. Statistical Analysis

The statistical significance of any differences was analyzed using the unpaired Student t-test or Fisher exact test for two groups and ANOVA with Tukey's post hoc test for three groups, as indicated. All statistical analyses were performed using IBM SPSS version 22.0 (IBM Corp., Armonk, NY, USA). The data are expressed as means±SD. Two-sided P<0.05 was considered statistically significant.

RESULTS

1. Patient Characteristics

We enrolled 184 consecutive patients with IBS (93 men and 91 women) and 49 asymptomatic controls (29 men and 20 women). Characteristics of the patients with IBS and asymptomatic controls are shown in Table 1. The mean age of the IBS group (58.9±16.1 years) was significantly lower than that of the control group (61.4±15.4 years) (P=0.010). There was not a significant difference in gender in either group (P=0.340). The participants with IBS consisted of 80 patients with IBS-C (37 men and 43 women), 45 with IBS-D (26 men and 19 women), and 59 with IBS-M (30 men and 29 women). No cases of unsubtyped IBS were observed. Characteristics of patients with different IBS subtypes are shown in Table 2. There were no significant age and gender differences in the IBS subtype groups (P=0.200).

2. Colonic Dysmotility

Persistence of colonic dysmotility for >8 minutes after administration of an antispasmodic agent was more frequently observed in the IBS group than in the control group (28.8% vs. 2.0%, P<0.001) (Table 1). Colonic dysmotility was more frequent in the IBS-D than IBS-C and IBS-M groups (IBS-C 28.8% vs. IBS-D 60.0% vs. IBS-M 5.1%, P<0.001) (Table 2). Most of the colonic dysmotility observed in IBS-D was excessive peristalsis (Fig. 1B), which caused incontinent excessive passing of gas or water through the anus during colonoscopy. Most of the colonic dysmotility observed in IBS-C was segmental movement (Fig. 1C), which made it difficult to advance the colonoscope through the retracted rings of the colon. Most of the IBS patients with persistent colonic dysmotility had experienced stress related to the symptoms (Table 3). In most cases, colonic dysmotility ceased after participants were informed that the endoscope had reached the cecum, the endpoint of the colon (data not shown).

3. Morphological Abnormality

Barium enema or CTC was performed in 47 and 126 participants with IBS, respectively (Fig. 3). Colonic morphological abnormality was more frequent in the IBS group than in the control group (77.7% vs. 24.5%, P<0.001) (Table 1). This morphological abnormality was more frequent in IBS-M and IBS-C than in IBS-D (IBS-C 77.5% vs. IBS-D 48.9% vs. IBS-M 100.0%, P<0.001) (Table 2). Most of the IBS patients with only colonic morphological abnormality had not experienced stress related to the symptoms (Table 3).

4. Cecal Intubation Time

No complications directly related to colonoscopy, including perforation and bleeding, were observed and no participant experienced more than tolerable pain. Cecal intubation was impossible in only one male patient with IBS-M; thus, the cecal intubation rate was 99.5% in patients with IBS and 100% in the control group. The case of incomplete intubation was excluded from calculation of the average time. Cecal intubation time was significantly longer in the IBS group than in the control group (12.1±6.9 minutes vs. 4.6±1.9 minutes, P<0.001) (Table 1). There was no significant difference in cecal intubation time among the IBS subgroups (IBS-C 12.7±8.0 minutes vs. IBS-D 10.7±1.9 minutes vs. IBS-M 12.3±5.9 minutes, P=0.300) (Table 2).

DISCUSSION

We demonstrated that persistent colonic dysmotility after administration of an antispasmodic agent and morphological abnormality were more frequent in patients with IBS than in asymptomatic controls. These abnormalities made colonoscope insertion difficult, and cecal intubation time was significantly longer in the IBS group than in the control group.

IBS is a functional gastrointestinal disorder with a high prevalence that has a considerable impact on quality of life.1 It is crucial to perform correct diagnosis of IBS and initiate appropriate management immediately.2 18 There are few pathognomonic tests for IBS; therefore, it is a challenge for clinicians to differentiate IBS from other gastrointestinal disorders objectively. Visceral hypersensitivity and hyperalgesia play important roles in the pathophysiology of IBS.19 20 Examinations of gastrointestinal function, such as colonic manometry, anorectal manometry, measurement of gastrointestinal transit, or colorectal barostat, are useful to support the diagnosis of IBS and differentiate it from other functional gastrointestinal disorders. However, these examinations are still unavailable in most hospitals and are difficult to perform routinely.19

Colonoscopic examination is necessary to rule out colorectal cancer, IBD, and colon diverticular diseases among patients with IBS symptoms. Age >50 years and warning signs such as anemia and weight loss require colonoscopic examination to distinguish these organic diseases from IBS.2 19 Some researchers have attempted to establish a difference in pain perception during colonoscopic examination between individuals with and without IBS.5 21 22 Cullingford et al.21 reported that the intensity of pain during colonoscopic examination was higher in patients with IBS than in patients without IBS, suggesting that pain is a useful tool for diagnosing IBS. Most of the pain and discomfort experienced during colonoscopy are caused by stretching of the mesentery from the loop at the sigmoid colon, distension of the colonic wall by over-insufflation, and the perception of pain.5 High sensitivity to colonic stretching in IBS is attributed to peripheral sensitization of mechanoreceptors and abnormal central processing of visceral sensory information.23 Kim et al.5 used the difference in pain, experienced between individuals with and without IBS to evaluate the visceral hypersensitivity of IBS. They concluded that colonoscopy could be a diagnostic tool for identifying IBS caused by visceral hypersensitivity to colonoscopy and colonic spasms.

We have reported a technique for colonoscope insertion without sedation.12 13 14 15 In this technique, 200 mL of water is infused at the rectosigmoid and complete air suction is performed from the rectosigmoid. This forces the flow of water to the descending colon, and the rectosigmoid straightens and shortens by itself. A “corkscrew” twist of the colonoscope in accordance with the twist of the sigmoid colon allows the colonoscope to proceed to the descending colon without looping.12 During intubation, the surface of the water and twisting of the colon indicate the colonic morphology.15 This technique causes minimal change in colonic volume and only slightly stretches the sigmoid colon, which makes it possible to perform colonoscopy without sedatives.12 In recent years, a water-aided colonoscopy technique similar to ours has been developed to reduce pain during nonsedative colonoscopy,24 25 and it can be used therapeutically for sigmoid volvulus.26 27

In the present study, persistence of colonic dysmotility for >8 minutes after administration of an antispasmodic agent was more frequently observed in patients with IBS than in controls. The persistent colonic dysmotility observed among patients with IBS-D was excessive peristalsis that caused excessive passing of gas and water through the anus, which could not be controlled by patients. The persistent colonic dysmotility observed among patients with IBS-C was segmental movement that was caused by a combination of retraction rings and expanded colonic lumen. The retraction rings contracted and relaxed at the same point, which caused a sensation of bloating. Most patients were aware that their IBS symptoms were caused by mental stress. Colonic dysmotility appeared to be caused by mental stress associated with the colonoscopy procedure, and it ceased upon the administration of sedatives or at the time when the endoscope reached the cecum. This dysmotility may explain the IBS symptoms such as diarrhea and constipation evoked by mental stress.

Colonic morphological abnormality was more frequent in the IBS group than in the control group. Abnormalities such as sigmoid colon malrotation and mesocolon descendens cause acute angulation and elongation of the colon, which lead to difficulties with colonoscope insertion.15 28 29 In the present study, colonic morphological abnormality was frequent in the IBS-M and IBS-C subgroups, and most of the patients were not aware of any mental stress causing their IBS symptoms. Insertion of the colonoscope into the cecum is often difficult in patients with colonic morphological abnormality, and most patients are aware of tolerable pain or discomfort, which is similar to their IBS symptoms, when the colonoscope passes the area of colonic morphological abnormality.

Cecal intubation time was significantly longer in the IBS group than in the control group. Difficulty with cecal intubation caused by colonic dysmotility and/or colonic morphological abnormality suggests that these defects could cause defecatory disorder and pain in IBS. It is possible that this classification of IBS contributes to the potential to select the appropriate management for each patient. In addition, patients with IBS involving morphological abnormality and/or colonic dysmotility were frequently convinced by our explanation of their symptoms using colonoscopic findings and/or CTC images, resulting in biofeedback.

Although the present study seems to present an attractive endoscopically and radiographically novel method of evaluation of IBS, it has several limitations. This study was a retrospective study, and consecutive patients with IBS who were scheduled to undergo colonoscopy were recruited; thus, the patients might not be representative of the general population in terms of demographic characteristics such as age and sex. It was also difficult to enroll asymptomatic young participants, while patients aged >50 years were more likely to undergo colonoscopy for colorectal screening. However, the morphological features depend on anatomical factors; thus we think the effects of age on colonic morphological abnormality may be relatively small.17 Although colonic morphology was assessed using CTC or barium enema, unified assessment was desirable. Since a single endoscopist assessed colonic dysmotility, and the commencement of the effect of antispasmodic agents varies among patients, the method of colonic dysmotility evaluation may be relatively subjective. The incidence of colonic morphological abnormality varies worldwide.30 Our study was an assessment of IBS in the Japanese population, thus there may be geographical differences.31 Of course, our conception in this study cannot explain all of the pathophysiology of IBS.

In conclusion, we suggest that there are some patients with IBS involving colonic dysmotility and/or morphological abnormality. These abnormalities manifested as technical difficulties with cecal intubation may partially explain the pathophysiology of IBS. Unsedated colonoscopy combined with radiographic findings is useful for excluding organic colonic disease, as well as for functional evaluation in patients with IBS.

Acknowledgments

ACKNOWLEDGEMENTS

The authors thank Dr. Juntaro Matsuzaki for his assistance with statistical analysis.

NOTES

Financial support: None.

Conflict of interest: None.

REFERENCES

1. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654–660.PMID: 10982758.Article PubMed
2. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377–1390.PMID: 16678553.Article PubMed
3. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712–721.e4.PMID: 22426087.Article PubMed
4. Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med 1987;151:373–385.PMID: 3617051.Article PubMed
5. Kim ES, Cheon JH, Park JJ, et al. Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol 2010;25:1232–1238.PMID: 20594249.Article PubMed
6. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007;56:1770–1798.PMID: 17488783.Article PubMed PMC
7. Lee KJ, Tack J. Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:493–498.PMID: 20414959.Article PubMed
8. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired postinfectious irritable bowel syndrome. Gut 2003;52:523–526.PMID: 12631663.Article PubMed PMC
9. Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut 2003;52:91–93.PMID: 12477767.Article PubMed PMC
10. Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol 2001;96:1499–1506.PMID: 11374689.Article PubMed
11. Mizukami T, Horiuchi Y, Mori N, et al. Endoscopic evaluation of colonic movement after the administration of a spasmolytic drug to irritable bowel syndrome patients: application to diagnosis and therapy. J Psychosom Digest Dis 2009;16:91–97.
12. Mizukami T, Yokoyama A, Imaeda H, Kumai K. Collapse-submergence method: simple colonoscopic technique combining water infusion with complete air removal from the rectosigmoid colon. Dig Endosc 2007;19:43–48.Article
13. Mizukami T, Hibi T. How I teach my trainees “water navigation colonoscopy”. Am J Clin Med 2010;7:144–146.
14. Asai S, Fujimoto N, Tanoue K, et al. Water immersion colonoscopy facilitates straight passage of the colonoscope through the sigmoid colon without loop formation: randomized controlled trial. Dig Endosc 2015;27:345–353.PMID: 25413483.Article PubMed
15. Sugimoto S, Mizukami T. Diagnostic and therapeutic applications of water-immersion colonoscopy. World J Gastroenterol 2015;21:6451–6459.PMID: 26074684.Article PubMed PMC
16. Mizukami T, Ogata H, Hibi T. “Passive-bending colonoscope” significantly improves cecal intubation in difficult cases. World J Gastroenterol 2012;18:4454–4456.PMID: 22969214.Article PubMed PMC
17. Khashab MA, Pickhardt PJ, Kim DH, Rex DK. Colorectal anatomy in adults at computed tomography colonography: normal distribution and the effect of age, sex, and body mass index. Endoscopy 2009;41:674–678.PMID: 19670134.Article PubMed
18. Weinberg DS, Smalley W, Heidelbaugh JJ, Sultan S. American Gastroenterological Association. American Gastroenterological Association Institute guideline on the pharmacological management of irritable bowel syndrome. Gastroenterology 2014;147:1146–1148.PMID: 25224526.Article PubMed
19. Fukudo S, Kaneko H, Akiho H, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol 2015;50:11–30.PMID: 25500976.Article PubMed
20. Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002;122:1771–1777.PMID: 12055583.Article PubMed
21. Cullingford GL, Coffey JF, Carr-Locke DL. Irritable bowel syndrome: can the patient’s response to colonoscopy help with diagnosis? Digestion 1992;52:209–213.PMID: 1459355.Article PubMed
22. Shah SG, Brooker JC, Thapar C, Williams CB, Saunders BP. Patient pain during colonoscopy: an analysis using real-time magnetic endoscope imaging. Endoscopy 2002;34:435–440.PMID: 12048623.Article PubMed PDF
23. Whitehead WE, Holtkotter B, Enck P, et al. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology 1990;98(5 Pt 1): 1187–1192.PMID: 2323511.Article PubMed
24. Leung CW, Kaltenbach T, Soetikno R, Wu KK, Leung FW, Friedland S. Water immersion versus standard colonoscopy insertion technique: randomized trial shows promise for minimal sedation. Endoscopy 2010;42:557–563.PMID: 20593332.Article PubMed
25. Anderson JC. Water-aided colonoscopy. Gastrointest Endosc Clin N Am 2015;25:211–226.PMID: 25839683.Article PubMed
26. Sugimoto S, Hosoe N, Mizukami T, et al. Effectiveness and clinical results of endoscopic management of sigmoid volvulus using unsedated water-immersion colonoscopy. Dig Endosc 2014;26:564–568.PMID: 24533946.Article PubMed
27. Sugimoto S, Mizukami T, Ito T, et al. Endoscopic detorsion for sigmoid volvulus using unsedated water-immersion colonoscopy. Endoscopy 2013;45(Suppl 2): E263–E264.PMID: 24008457.Article PubMed PDF
28. Saunders BP, Halligan S, Jobling C, et al. Can barium enema indicate when colonoscopy will be difficult? Clin Radiol 1995;50:318–321.PMID: 7743720.Article PubMed
29. Hanson ME, Pickhardt PJ, Kim DH, Pfau PR. Anatomic factors predictive of incomplete colonoscopy based on findings at CT colonography. AJR Am J Roentgenol 2007;189:774–779.PMID: 17885044.Article PubMed
30. Madiba TE, Haffajee MR, Sikhosana MH. Radiological anatomy of the sigmoid colon. Surg Radiol Anat 2008;30:409–415.PMID: 18385923.Article PubMed
31. Fukudo S, Hahm KB, Zhu Q, et al. Survey of clinical practice for irritable bowel syndrome in East Asian countries. Digestion 2015;91:99–109.PMID: 25632923.Article PubMed

Fig. 1

Colonoscopic view of colonic dysmotility. (A) Normal view without colonoscopic dysmotility. (B) Spontaneous colonic excessive peristalsis, as frequently observed during colonoscopy in patients with IBS with diarrhea. (C) Colonic dysmotility with segmental features, as observed during colonoscopy in a proportion of patients with IBS with constipation.

Fig. 2

Three-dimensional colonic morphology from CT colonography. Representative figures of sigmoid colon malrotation (A), and mesocolon descendens (B, C). White lines represent the center-lines for endoluminal navigation that shows unusual colonic course. White arrows indicate acute angulation of colon due to mesocolon descendens.

Fig. 3

Characteristics of patients with IBS evaluated using CTC or barium enema. IBS-D, IBS with diarrhea; M, male; F, female; BE, barium enema; CTC, CT colonography; IBS-M, mixed IBS; IBS-C, IBS with constipation.

Table 1

Background and Endoscopic/Radiographic Findings in All Participants Variable

Variable	Control group (n=49)	IBS group (n=184)	P-value
Age (yr)	61.4±15.4	58.9±16.1	0.010^a
Male/female	29 (59.2)/20 (40.8)	93 (50.5)/91 (49.5)	0.340^b
Dysmotility	1 (2.0)	53 (28.8)	<0.001^b
Morphological abnormality	12 (24.5)	143 (77.7)	<0.001^b
Insertion time (min)	4.6±1.9	12.1±6.9	<0.001^a

Values are presented as mean±SD or number (%).

^aUnpaired Student t-test.

^bFisher exact test.

Table 2

Background and Endoscopic/Radiographic Findings in Each IBS Subgroup

Variable	IBS-D (n=45)	IBS-M (n=59)	IBS-C (n=80)	P-value^a
Age (yr)	56.1±17.5	61.7±15.9	58.4±15.2	0.200
Male/female	26 (57.8)/19 (42.2)	30 (50.8)/29 (49.2)	37 (46.3)/43 (53.8)	0.200
Dysmotility	27 (60.0)^b,c	3 (5.1)^b,d	23 (28.8)^c,d	<0.001
Morphological abnormality	22 (48.9)^b,c	59 (100.0)^b,d	62 (77.5)^c,d	<0.001
Insertion time (min)	10.7±1.9	12.3±5.9	12.7±8.0	0.300

Values are presented as mean±SD or number (%).

^aOne-way ANOVA.

^bSignificant difference from IBS-C using Tukey's post hoc analysis.

^cSignificant difference from IBS-M using Tukey's post hoc analysis.

^dSignificant difference from IBS-D using Tukey's post hoc analysis.

IBS-D, IBS with diarrhea; IBS-M, mixed IBS; IBS-C, IBS with constipation.

Table 3

Differences Based on Sex Regarding the Background and Findings in Each IBS Subgroup and Controls

Variable	IBS-D (n=45)		IBS-M (n=59)		IBS-C (n=80)		Control (n=49)
Variable	Male (n=26)	Female (n=19)	Male (n=30)	Female (n=29)	Male (n=37)	Female (n=43)	Male (n=29)	Female (n=20)
Age (yr)	57.4±17.8	54.4±18.8	66.6±13.8	56.6±15.9	62.9±12.8	54.5±15.8	66.0±12.2	61.9±12.5
Onset age (yr)	28.3±18.8	32.7±19.8	41.7±19.6	33.4±16.7	40.1±19.9	34.0±18.1	NA	NA
Dysmotility	19 (73.1)	8 (42.1)	3 (10.0)	0	19 (51.4)	4 (9.3)	1 (3.4)	0
Related stress	18 (69.2)	8 (42.1)	4 (13.3)	1 (3.4)	15 (40.5)	3 (7.0)	NA	NA
Morphological abnormality	8 (30.8)	14 (73.7)	59 (100.0)	29 (100.0)	22 (59.5)	40 (93.0)	7 (24.1)	5 (25.0)
Insertion time (min)	8.4±4.3	13.8±5.9	11.6±6.3	13.0±5.5	11.5±8.8	13.8±6.9	4.5±2.2	4.7±1.6

Values are presented as mean±SD or number (%).

IBS-D, IBS with diarrhea; IBS-M, mixed IBS; IBS-C, IBS with constipation; NA, not available.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Ultrasound Imaging Equipment for Evaluating Chronic Constipation in Home Healthcare: A Review Article
Yohei Okawa
Gastrointestinal Disorders.2025; 7(1): 12. CrossRef
Efficacy of Glycicumarin and Isoliquiritigenin in Suppressing Colonic Peristalsis in Both an Animal Model and a Clinical Trial
Reo Kobayashi, Ken Inoue, Satoshi Sugino, Ryohei Hirose, Toshifumi Doi, Akihito Harusato, Osamu Dohi, Naohisa Yoshida, Kazuhiko Uchiyama, Takeshi Ishikawa, Tomohisa Takagi, Hideyuki Konishi, Yasuko Hirai, Katsura Mizushima, Yuji Naito, Yoshito Itoh
Biological and Pharmaceutical Bulletin.2024; 47(2): 373. CrossRef
Diagnostic Ability of Ultrasonography Compared with Computed Tomography for Assessing Rectal Feces
Noboru Misawa, Masaru Matsumoto, Momoko Tsuda, Shigeki Tamura, Tsutomu Yoshihara, Keiichi Ashikari, Takaomi Kessoku, Hidenori Ohkubo, Takuma Higurashi, Hiromi Sanada, Mototsugu Kato, Atsushi Nakajima
Journal of the Anus, Rectum and Colon.2024; 8(2): 126. CrossRef
Evidence-Based Clinical Guidelines for Chronic Constipation 2023
Eikichi Ihara, Noriaki Manabe, Hidenori Ohkubo, Naotaka Ogasawara, Haruei Ogino, Kazuki Kakimoto, Motoyori Kanazawa, Hidejiro Kawahara, Chika Kusano, Shiko Kuribayashi, Akinari Sawada, Tomohisa Takagi, Shota Takano, Toshihiko Tomita, Toshihiro Noake, Mari
Digestion.2024; : 1. CrossRef
The effect of alverine citrate plus simethicone (Meteospazmyl ) on effectiveness and tolerability of bowel preparation for colonoscopy
S.V. Kashin, D.V. Zavyalov, A.V. Sidneva
Russian Journal of Evidence-Based Gastroenterology.2023; 12(2): 34. CrossRef
Current Management of Chronic Constipation in Japan
Tatsuhiro Masaoka
The Keio Journal of Medicine.2023; 72(4): 95. CrossRef
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
Shin Fukudo, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, Tastuhiro Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiro
Journal of Gastroenterology.2021; 56(3): 193. CrossRef
NUTRITIONAL STATUS, QUALITY OF LIFE AND LIFE HABITS OF WOMEN WITH IRRITABLE BOWEL SYNDROME: A CASE-CONTROL STUDY
Ana Paula Monteiro de MENDONÇA, Luciana Miyuki YAMASHITA, Esther Dantas SILVA, Isabela SOLAR, Larissa Ariel Oliveira SANTOS, Ana Carolina Junqueira VASQUES
Arquivos de Gastroenterologia.2020; 57(2): 114. CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome

Intest Res. 2017;15(2):236-243. Published online April 27, 2017

DOI: https://doi.org/10.5217/ir.2017.15.2.236

XML Download

Figure

Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome

Fig. 1 Colonoscopic view of colonic dysmotility. (A) Normal view without colonoscopic dysmotility. (B) Spontaneous colonic excessive peristalsis, as frequently observed during colonoscopy in patients with IBS with diarrhea. (C) Colonic dysmotility with segmental features, as observed during colonoscopy in a proportion of patients with IBS with constipation.

Fig. 2 Three-dimensional colonic morphology from CT colonography. Representative figures of sigmoid colon malrotation (A), and mesocolon descendens (B, C). White lines represent the center-lines for endoluminal navigation that shows unusual colonic course. White arrows indicate acute angulation of colon due to mesocolon descendens.

Fig. 3 Characteristics of patients with IBS evaluated using CTC or barium enema. IBS-D, IBS with diarrhea; M, male; F, female; BE, barium enema; CTC, CT colonography; IBS-M, mixed IBS; IBS-C, IBS with constipation.

Fig. 1

Fig. 2

Fig. 3

Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome

Table 1

Background and Endoscopic/Radiographic Findings in All Participants Variable

Variable	Control group (n=49)	IBS group (n=184)	P-value
Age (yr)	61.4±15.4	58.9±16.1	0.010^a
Male/female	29 (59.2)/20 (40.8)	93 (50.5)/91 (49.5)	0.340^b
Dysmotility	1 (2.0)	53 (28.8)	<0.001^b
Morphological abnormality	12 (24.5)	143 (77.7)	<0.001^b
Insertion time (min)	4.6±1.9	12.1±6.9	<0.001^a

Values are presented as mean±SD or number (%).

^aUnpaired Student t-test.

^bFisher exact test.

Table 2

Background and Endoscopic/Radiographic Findings in Each IBS Subgroup

Variable	IBS-D (n=45)	IBS-M (n=59)	IBS-C (n=80)	P-value^a
Age (yr)	56.1±17.5	61.7±15.9	58.4±15.2	0.200
Male/female	26 (57.8)/19 (42.2)	30 (50.8)/29 (49.2)	37 (46.3)/43 (53.8)	0.200
Dysmotility	27 (60.0)^b,c	3 (5.1)^b,d	23 (28.8)^c,d	<0.001
Morphological abnormality	22 (48.9)^b,c	59 (100.0)^b,d	62 (77.5)^c,d	<0.001
Insertion time (min)	10.7±1.9	12.3±5.9	12.7±8.0	0.300

Values are presented as mean±SD or number (%).

^aOne-way ANOVA.

^bSignificant difference from IBS-C using Tukey's post hoc analysis.

^cSignificant difference from IBS-M using Tukey's post hoc analysis.

^dSignificant difference from IBS-D using Tukey's post hoc analysis.

IBS-D, IBS with diarrhea; IBS-M, mixed IBS; IBS-C, IBS with constipation.

Table 3

Differences Based on Sex Regarding the Background and Findings in Each IBS Subgroup and Controls

Variable	IBS-D (n=45)		IBS-M (n=59)		IBS-C (n=80)		Control (n=49)
Variable	Male (n=26)	Female (n=19)	Male (n=30)	Female (n=29)	Male (n=37)	Female (n=43)	Male (n=29)	Female (n=20)
Age (yr)	57.4±17.8	54.4±18.8	66.6±13.8	56.6±15.9	62.9±12.8	54.5±15.8	66.0±12.2	61.9±12.5
Onset age (yr)	28.3±18.8	32.7±19.8	41.7±19.6	33.4±16.7	40.1±19.9	34.0±18.1	NA	NA
Dysmotility	19 (73.1)	8 (42.1)	3 (10.0)	0	19 (51.4)	4 (9.3)	1 (3.4)	0
Related stress	18 (69.2)	8 (42.1)	4 (13.3)	1 (3.4)	15 (40.5)	3 (7.0)	NA	NA
Morphological abnormality	8 (30.8)	14 (73.7)	59 (100.0)	29 (100.0)	22 (59.5)	40 (93.0)	7 (24.1)	5 (25.0)
Insertion time (min)	8.4±4.3	13.8±5.9	11.6±6.3	13.0±5.5	11.5±8.8	13.8±6.9	4.5±2.2	4.7±1.6

Values are presented as mean±SD or number (%).

IBS-D, IBS with diarrhea; IBS-M, mixed IBS; IBS-C, IBS with constipation; NA, not available.

Table 1 Background and Endoscopic/Radiographic Findings in All Participants Variable

Values are presented as mean±SD or number (%).

^aUnpaired Student t-test.

^bFisher exact test.

Table 2 Background and Endoscopic/Radiographic Findings in Each IBS Subgroup

Values are presented as mean±SD or number (%).

^aOne-way ANOVA.

^bSignificant difference from IBS-C using Tukey's post hoc analysis.

^cSignificant difference from IBS-M using Tukey's post hoc analysis.

^dSignificant difference from IBS-D using Tukey's post hoc analysis.

IBS-D, IBS with diarrhea; IBS-M, mixed IBS; IBS-C, IBS with constipation.

Table 3 Differences Based on Sex Regarding the Background and Findings in Each IBS Subgroup and Controls

Values are presented as mean±SD or number (%).

IBS-D, IBS with diarrhea; IBS-M, mixed IBS; IBS-C, IBS with constipation; NA, not available.